Doxorubicin and olaratumab versus doxorubicin, ifosfamide, and mesna for treatment of advanced soft tissue sarcomas

Kathryn J. Hammer, Vanessa C. Copeland, Elizabeth T. Loggers, Seth M. Pollack, Michael J. Wagner, Lee D. Cranmer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Doxorubicin and olaratumab versus doxorubicin, ifosfamide, and mesna for treatment of advanced soft tissue sarcomas'. Together they form a unique fingerprint.

Medicine & Life Sciences